Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Northwest Biotherapeutics (NWBO) over the last 16 years, with Q3 2025 value amounting to $3.1 million.

  • Northwest Biotherapeutics' Exchange Rate Effect rose 19806.53% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 13390.45%. This contributed to the annual value of $1.3 million for FY2024, which is 34760.99% up from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Exchange Rate Effect of $3.1 million as of Q3 2025, which was up 19806.53% from -$3.9 million recorded in Q2 2025.
  • Northwest Biotherapeutics' 5-year Exchange Rate Effect high stood at $4.7 million for Q3 2022, and its period low was -$3.9 million during Q2 2025.
  • Over the past 5 years, Northwest Biotherapeutics' median Exchange Rate Effect value was $236000.0 (recorded in 2021), while the average stood at $273684.2.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 150937.5% in 2022, then plummeted by 2295294.12% in 2025.
  • Northwest Biotherapeutics' Exchange Rate Effect (Quarter) stood at $462000.0 in 2021, then crashed by 706.49% to -$2.8 million in 2022, then soared by 63.95% to -$1.0 million in 2023, then skyrocketed by 451.78% to $3.6 million in 2024, then decreased by 12.97% to $3.1 million in 2025.
  • Its Exchange Rate Effect was $3.1 million in Q3 2025, compared to -$3.9 million in Q2 2025 and -$1.6 million in Q1 2025.